دورية أكاديمية
B3 - Impact of metabolic syndrome on clinical outcome of castration resistant prostate cancer (CRPC) patients treated with abiraterone and enzalutamide
| العنوان: | B3 - Impact of metabolic syndrome on clinical outcome of castration resistant prostate cancer (CRPC) patients treated with abiraterone and enzalutamide |
|---|---|
| المؤلفون: | Conteduca, V., Caffo, O., Galli, L., Maugeri, A., Scarpi, E., Maines, F., Chiuri, V.E., Lolli, C., Kinspergher, S., Schepisi, G., Santoni, M., Santini, D., Fratino, L., Burgio, S.L., Salvi, S., Menna, C., de Giorgi, U. |
| المصدر: | In Annals of Oncology October 2017 28 Supplement 6:vi17-vi17 |
| قاعدة البيانات: | ScienceDirect |
كن أول من يترك تعليقا!